Search
Korro Bio Inc
KRROAdd to Watchlist
12.990USD
+1.940+17.56%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
187.35MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Korro Bio Inc is 8.00, ranking 165 out of 389 in the Biotechnology & Medical Research industry. The average price target is 9.50, with a high of 147.00 and a low of 7.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
19.556
Target Price
+50.54%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Korro Bio Inc
KRRO
10
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Korro Bio Inc's expected revenue for the next quarter?
Korro Bio Inc's expected revenue is 214.29K.
What is Korro Bio Inc's price target?
Analysts forecast that Korro Bio Inc's price target is USD 9.50, with the highest forecast at USD 147.00 and the lowest forecast at USD 7.00.
How have Korro Bio IncKRRO's recent earnings per share performed?
The market expectation was USD -1.69, while Korro Bio IncKRRO's earnings per share (EPS) for the previous quarter was USD -5.32. EPS for the next quarter is expected at USD -1.27.
What is the analyst rating for Korro Bio Inc?
Based on the ratings of Korro Bio Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
